| Hesperidin (Diosmin EP Impurity B) | 520-26-3 | C28H34O15 |
| Heterochromatic concealment | 4702-34-5 | C9H8O2 |
| Hetrombopag Ethanolamine | 1257792-41-8 | C25H22N4O5 |
| Hexacosanoic Acid-d4 | 1194984-85-4 | C26H52O2 |
| Hexadecyl isothiocyanate | 4426-87-3 | C17H33NS |
| Hexaethyldisiloxane | 994-49-0 | C12H30OSi2 |
| Hexahydro-N-[(4-methylphenyl)sulfonyl]-cyclopenta[c]pyrrole-2(1H)-carboxamide | 1136426-19-1 | C15H20N2O3S |
| Hexahydrocurcumin Impurity | 36062-05-2 | C21H26O6 |
| Hexahydrocurcumin-d6 | Not available | C21H26O6 |
| Hexahydrotrandolapril | Not available | C24H40N2O5 |
| Hexanedioic Acid 1-(3-Hydroxy-2,2-Dimethylpropyl) Ester | 856322-18-4 | C11H20O5 |
| Hexanedioic Acid Bis-(2-carboxyphenyl) Ester | 69638-07-9 | C20H18O8 |
| Hexanedioic Acid Mono-(2-carboxyphenyl) Ester | 863985-44-8 | C13H14O6 |
| Hexetidine Imp. C (EP): 2,6-Bis(2-ethylhexyl)-7a-methyl- hexahydro-1H-imidazo[1,5-c]imidazole (Hexedine) | 5980-31-4 | C22H45N3 |
| Hexyl Methanesulfonate | 16156-50-6 | C7H16O3S |
| Hexyl N-(4-Aminobenzenecarboximidoyl)carbamate Hydrochloride | 1307233-93-7 | C14H22ClN3O2 |
| Hexylresorcinol for system suitability | 136-77-6 | C12H18O2 |
| Hexylresorcinol Imp. A (EP): Phenol | 108-95-2 | C6H6O |
| Hexylresorcinol Imp. B (EP): Resorcinol | 108-46-3 | C6H6O2 |
| Hidrocortisona | 50-23-7 | C21H30O5 |
| Hippuric acid | 495-69-2 | C9H9NO3 |
| Histamine-alpha,alpha,beta,beta-D4 Dihydrochloride | 344299-48-5 | C5H11Cl2N3 |
| Histidine | 71-00-1 | C6H9N3O2 |
| Histrelin | 76712-82-8 | C66H86N18O12 |
| Homatropine methylbromide for system suitability | 80-49-9 | C17H24BrNO3 |
| Homatropine Methylbromide Imp. C (EP): (2RS)-2-Hydroxy-2-phenylacetic Acid (Mandelic Acid) | 90-64-2 | C8H8O3 |
| Homatropine Methylbromide Imp. D (EP) as Bromide: (1R,2R,4S,5S,7s)-7- [[(2S)-3-Hydroxy-2-phenylpropanoyl]oxy]-9,9- dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]- nonane Bromide (Methylhyoscine Bromide) | 155-41-9 | C18H24BrNO4 |
| Homatropine Methylbromide Imp. F (EP): Methyl (2RS)-2-Hydroxy-2- phenylacetate (Methyl Mandelate) | 4358-87-6 | C9H10O3 |
| Homatropine N-Oxide Hydrochloride | Not available | C16H22ClNO4 |
| Homatropine N-Oxide Hydrochloride | Not available | C16H22ClNO4 |
| HomoCapsaicin I | 58493-48-4 | C19H29NO3 |
| HomoDihydroCapsaicin I | 20279-06-5 | C19H31NO3 |
| Homogentisic Acid-13C6 | 1216468-48-2 | C8H8O4 |
| Homoserine lactone | 1192-20-7 | C4H7NO2 |
| Homoserine Lactone (Hydrochloride) | 42417-39-0 | C4H8ClNO2 |
| Hopantenate calcium salt | 17097-76-6 | C20H38CaN2O11 |
| Hordenine Hydrochloride (4-Hydroxy-N,N-dimethylphenethylamine Hydrochloride) | 6027-23-2 | C10H16ClNO |
| Hybutimibe Impurity 1 | 1266548-74-6 | C25H21F2NO3 |
| Hydrazine monohydrochloride | 2644-70-4 | H5ClN2 |
| Hydrazine sulfate | 10034-93-2 | H6N2O4S |
| Hydrochloride | 13338-49-3 | C4H8Cl2N2 |
| Hydrochloride | 72830-09-2 | C8H11Cl2NO2 |
| Hydrochloride | 879646-17-0 | C15H23ClN2O4 |
| Hydrochloride | 246021-75-0 | C10H16ClN5O2 |
| Hydrochlorothiazide EP Impurity B | 121-30-2 | C6H8ClN3O4S2 |
| Hydrochlorothiazide EP Impurity D | 5233-42-1 | C7H7Cl2N3O4S2 |
| Hydrochlorothiazide for peak identification | 58-93-5 | C7H8ClN3O4S2 |
| Hydrochlorothiazide Imp. A (EP): Chlorothiazide | 58-94-6 | C7H6ClN3O4S2 |
| Hydrochlorothiazide Imp. B (EP): 4-Amino-6-chlorobenzene- 1,3-disulphonamide (Salamide) | 121-30-2 | C6H8ClN3O4S2 |
| Hydrochlorothiazide Impurity 3 | 4878-36-8 | C5H5ClN4O2 |
| Hydrochlorothiazide Impurity 6 | 2089381-36-0 | C10H14ClNO6S2 |
| Hydrochlorothiazide Impurity 8 | 360-81-6 | C8H8N2O2S |
| Hydrochlorothiazide Impurity 9 | 364-96-5 | C8H6Cl2N2O2S |
| Hydrochlorothiazide Impurity 10 | 671-89-6 | C6H4Cl3NO4S2 |
| Hydrochlorothiazide Impurity 11 | 23141-75-5 | C7H7N3O4S2 |
| Hydrochlorothiazide Impurity 12 | 1668-63-9 | C8H12ClN3O4S2 |
| Hydrochlorothiazide Impurity 13 | 75304-18-6 | C8H10N2O3S |
| Hydrochlorothiazide Impurity 14 | 99418-26-5 | C6H6ClNO6S2 |
| Hydrochlorothiazide Impurity 15 | 96456-09-6 | C18H14Cl3N3O4S2 |
| Hydrochlorothiazide Impurity 16 | 4140-83-4 | C6H7ClN2O2S |
| Hydrochlorothiazide Impurity 17 | 1954-94-5 | C6H7ClN2O2S |
| Hydrochlorothiazide Impurity 18 | 527-20-8 | C6H2Cl5N |
| Hydrochlorothiazide Impurity 20 | 5250-72-6 | C6H7Cl2N3O4S2 |
| Hydrochlorothiazide Impurity 21 | 85119-88-6 | C6H9N3O5S2 |
| Hydrochlorothiazide Impurity 22 | 82205-98-9 | C7H9N3O5S2 |
| Hydrochlorothiazide Impurity 23 | 63779-86-2 | C7H7ClN4O5S2 |
| Hydrochlorothiazide Impurity 25 | 90794-87-9 | C10H11ClN2O4S |
| Hydrochlorothiazide Impurity 27 | 88345-43-1 | C6H8ClN3O4S2 |
| Hydrochlorothiazide Impurity 28 | 40642-90-8 | C6H9N3O4S2 |
| Hydrochlorothiazide Impurity 29 | 1027-12-9 | C8H12ClN3O4S2 |
| Hydrochlorothiazide Impurity 30 | 1090-97-7 | C10H16ClN3O4S2 |
| Hydrochlorothiazide Impurity C | 402824-96-8 | C15H16Cl2N6O8S4 |
| Hydrochlorothiazide Impurity F | 890-67-5 | C8H10ClN3O4S2 |
| Hydrochlorothiazide Impurity G | 1025-75-8 | C8H8ClN3O4S2 |
| Hydrochlorothiazide Impurity K | 23141-82-4 | C7H9N3O4S2 |
| Hydrochlorothiazide Impurity N | 89813-56-9 | C7H6ClN3O5S2 |
| Hydrochlorothiazide Impurity O | 3950-44-5 | C8H10ClN3O4S2 |
| Hydrochlorothiazide-13C,d2 | 1190006-03-1 | C7H8ClN3O4S2 |
| Hydrochlorothiazide-d2 | 1219798-89-6 | C7H8ClN3O4S2 |
| Hydrocinnamic Acid | 501-52-0 | C9H10O2 |
| Hydrocinnamic Acid (3-Phenylpropanoic Acid) | 501-52-0 | C9H10O2 |
| Hydrocodone for peak identification | 34195-34-1 | C22H29NO10 |
| Hydrocodone Hydrogen Tartrate 2.5-Hydrate Imp. A (EP) as Hemisulphate Pentahemihydrate: Morphine Hemisulphate Pentahemihydrate | 6211-15-0 | C34H50N2O15S |
| Hydrocodone Hydrogen Tartrate 2.5-Hydrate Imp. A (EP) as Hydrochloride Trihydrate: Morphine Hydrochloride Trihydrate | Not available | C17H26ClNO6 |
| Hydrocodone Hydrogen Tartrate 2.5-Hydrate Imp. C (EP) as Monohydrate: Codeine Monohydrate | 6059-47-8 | C18H23NO4 |
| Hydrocodone Hydrogen Tartrate 2.5-Hydrate Imp. C (EP) as Phosphate Hemihydrate: Codeine Phosphate Hemihydrate | 41444-62-6 | C36H50N2O15P2 |
| Hydrocodone Hydrogen Tartrate 2.5-Hydrate Imp. D (EP) as Hydrochloride: 4,5 -Epoxy-14- hydroxy-3-methoxy-17-methylmorphinan-6- one Hydrochloride (Oxycodone Hydrochloride) | 124-90-3 | C18H22ClNO4 |
| Hydrocodone Hydrogen Tartrate 2.5-Hydrate Imp. E (EP): 7,8-Didehydro-4,5 -epoxy-3- methoxy-17-methylmorphinan-6-one (Codeinone) | 467-13-0 | C18H19NO3 |
| Hydrocodone Hydrogen Tartrate 2.5-Hydrate Imp. F (EP): 7,8-Didehydro-4,5 -epoxy- 3,6 -dimethoxy-17-methylmorphinan (Methylcodeine; O-Methylcodeine) | 2859-16-7 | C19H23NO3 |
| Hydrocodone Hydrogen Tartrate 2.5-Hydrate Imp. H (EP): Diphenylmethanone (Benzophenone) | 119-61-9 | C13H10O |
| Hydrocodone N-Oxide | 909265-05-0 | C18H21NO4 |
| Hydrocodone Related Compound A | 847-86-9 | C18H23NO3 |
| Hydrocortisone 11,17,21-Triacetate | 3517-51-9 | C27H36O8 |
| Hydrocortisone 17-Acetate | 16463-74-4 | C23H32O6 |
| Hydrocortisone 17-Propionate 21-Acetate | 74050-20-7 | C26H36O7 |
| Hydrocortisone 21-Aldehyde Hydrate | 906337-64-2 | C21H30O6 |
| Hydrocortisone 21-Butyrate | 6677-99-2 | C25H36O6 |
| Hydrocortisone 21-hemisuccinate | 2203-97-6 | C25H34O8 |
| Hydrocortisone (9beta,11beta)-Epoxide | 10072-97-6 | C21H28O5 |
| Hydrocortisone Acetate EP Impurity C | 52-21-1 | C23H30O6 |
| Hydrocortisone Acetate EP Impurity D | 50-04-4 | C23H30O6 |
| Hydrocortisone Acetate EP Impurity E | 7753-60-8 | C23H30O5 |
| Hydrocortisone Acetate EP Impurity F | 1250-97-1 | C23H32O6 |
| Hydrocortisone Acetate EP Impurity G | 81968-66-3 | C25H34O7 |
| Hydrocortisone acetate for peak identification | 50-03-3 | C23H32O6 |
| Hydrocortisone Acetate Imp. A (EP): 11 ,17,21-Trihydroxypregn-4-ene-3,20-dione (Hydrocortisone) | 50-23-7 | C21H30O5 |
| Hydrocortisone Acetate Imp. C (EP): 11 ,17-Dihydroxy-3,20-dioxopregna-1,4-dien-21-yl Acetate (Prednisolone Acetate) | 52-21-1 | C23H30O6 |
| Hydrocortisone EP Impurity C (Prednisolone Acetate EP Impurity A) | 50-03-3 | C23H32O6 |
| Hydrocortisone EP Impurity D | 53-35-0 | C21H30O6 |
| Hydrocortisone EP Impurity E | 600-99-7 | C21H28O5 |
| Hydrocortisone EP Impurity F | 152-58-9 | C21H30O4 |
| Hydrocortisone EP Impurity G | 14760-49-7 | C21H28O5 |
| Hydrocortisone EP Impurity H | Not available | C21H30O6 |
| Hydrocortisone EP Impurity I | 103795-84-2 | C21H30O6 |
| Hydrocortisone EP Impurity J | 16463-74-4 | C23H32O6 |
| Hydrocortisone EP Impurity K | 640-87-9 | C23H32O5 |
| Hydrocortisone EP Impurity L (Hydrocortisone Acetate EP Impurity B) | 641-77-0 | C21H30O4 |
| Hydrocortisone EP Impurity M | 566-35-8 | C21H30O5 |
| Hydrocortisone EP Impurity N | Not available | C42H58O10 |
| Hydrocortisone EP Impurity O | 154032-37-8 | C21H30O6 |
| Hydrocortisone Hydrogen Succinate Imp. A (EP): Hydrocortisone | 50-23-7 | C21H30O5 |
| Hydrocortisone Hydrogen Succinate Imp. B (EP): Hydrocortisone Acetate | Not available | C23H32O6 |
| Hydrocortisone Imp. A (EP): Prednisolone | 50-24-8 | C21H28O5 |
| Hydrocortisone Imp. D (EP): 6 ,11 ,17,21-Tetrahydroxy- pregn-4-ene-3,20-dione (6 -Hydroxyhydrocortisone) | 53-35-0 | C21H30O6 |
| Hydrocortisone Imp. E (EP): 11 ,17,21-Trihydroxypregna- 4,6-diene-3,20-dione ( -Hydrocortisone) | 600-99-7 | C21H28O5 |
| Hydrocortisone Imp. F (EP): 17,21-Dihydroxypregn-4- ene-3,20-dione (Reichstein's Substance S) | 152-58-9 | C21H30O4 |
| Hydrocortisone Impurity 7 | 81456-46-4 | C28H40O7 |
| Hydrocortisone Impurity 11 | 139755-29-6 | C26H38O6 |
| Hydrocortisone Impurity 17 | 21590-20-5 | C21H26O2 |
| Hydrocortisone Impurity 20 | 103242-89-3 | C25H34O8 |
| Hydrocortisone Impurity 26 | 2435-02-1 | C23H28O6 |
| Hydrocortisone Impurity 27 | 1856-26-4 | C23H28O6 |
| Hydrocortisone Impurity 32 | 1142365-56-7 | C24H32O5 |
| Hydrocortisone Impurity 33 | 97154-22-8 | C24H32O5 |
| Hydrocortisone Impurity 34 | 74041-67-1 | C20H26O4 |
| Hydrocortisone Impurity 35 | 116816-80-9 | C21H26Cl2O3 |
| Hydrocortisone Impurity 36 | 95816-38-9 | C21H27IO3 |
| Hydrocortisone Impurity 37 | 24510-83-6 | C25H34O6 |
| Hydrocortisone Impurity 38 | 10184-70-0 | C21H28O4 |
| Hydrocortisone Impurity 39 | 3593-96-2 | C27H40O6 |
| Hydrocortisone Impurity 40 | 33762-00-4 | C21H28O5 |
| Hydrocortisone Impurity 44 | 220489-73-6 | C25H34O8 |
| Hydrocortisone Impurity 45 | 1960421-03-7 | C21H30O5 |
| Hydrocortisone Impurity 50 | 34542-58-0 | C24H32O6 |
| Hydrocortisone Impurity 54 | 7415-42-1 | C25H31NaO8 |
| Hydrocortisone Impurity 56 | 105562-12-7 | C21H28O4 |
| Hydrocortisone Impurity 57 | 105562-13-8 | C21H28O4 |
| Hydrocortisone Impurity 63 | 10215-75-5 | C25H32O8 |
| Hydrocortisone Impurity D | 53-35-0 | C21H30O6 |
| Hydrocortisone Impurity F | 152-58-9 | C21H30O4 |
| Hydrocortisone Impurity G | 14760-49-7 | C21H28O5 |
| Hydrocortisone Impurity L | 641-77-0 | C21H30O4 |
| Hydrogenated lecithin | 92128-87-5 | C42H84NO8P |
| Hydromorphone <I>N</I>-oxide hydrochloride | 109648-80-8 | C17H19NO4 |
| Hydromorphone hydrochloride EP impurity A | Not available | C34H36N2O6 |
| Hydromorphone hydrochloride EP impurity B | Not available | C17H19NO4 |
| Hydromorphone hydrochloride EP impurity D | Not available | C17H21NO3 |
| Hydromorphone Hydrochloride Imp. C (EP) as Hemisulphate Pentahemi- hydrate: Morphine Hemisulphate Pentahemi- hydrate | 6211-15-0 | C34H50N2O15S |
| Hydromorphone Hydrochloride Imp. C (EP) as Hydrochloride Trihydrate: Morphine Hydrochloride Trihydrate | Not available | C17H26ClNO6 |
| Hydromorphone N-Oxide Hydrochloride | Not available | C17H20ClNO4 |
| Hydromorphone N-oxide hydrochloride | 109648-80-8 | C17H19NO4 |
| Hydromorphone Related Compound A | 467-02-7 | C17H17NO3 |
| Hydroxy Adapalene | Not available | C28H28O4 |
| Hydroxy Bupropion-D6 | 1216893-18-3 | C13H18ClNO2 |
| Hydroxy Dabrafenib | 1195767-77-1 | C23H20F3N5O3S2 |
| Hydroxy Donepezil (Mixture of Diastereomers) | 197010-20-1 | C24H29NO4 |
| Hydroxy Ebastine | 210686-41-2 | C32H39NO3 |
| hydroxy Melphalan | 61733-01-5 | C13H19ClN2O3 |
| Hydroxy Pentoxifylline | 6493-06-7 | C13H20N4O3 |
| Hydroxy Ritonavir | 176655-56-4 | C37H48N6O6S2 |
| hydroxy Saxagliptin | 841302-24-7 | C18H25N3O3 |
| Hydroxy Torsemide | 99300-68-2 | C16H20N4O4S |
| Hydroxy Vildagliptin | Not available | C17H25N3O3 |
| Hydroxy Ziprasidone | 884305-08-2 | C21H21ClN4O2S |
| Hydroxy-2-phenylpropyl Carbamate | 25451-53-0 | C10H13NO3 |
| hydroxy-6,11-dihydro-5H-benzo[5,6]cyclo- | 133284-74-9 | C22H25ClN2O3 |
| Hydroxyalbendazole | Not available | C12H15N3O3S |
| Hydroxyasiatic acid | 18449-41-7 | C30H48O6 |
| Hydroxyatenolol | 68373-10-4 | C16H13N2Na2O6P |
| Hydroxybupropion (as (RS,RS)-cyclic Hemiketal) | 233600-52-7 | C13H18ClNO2 |
| Hydroxychlorodenafil (5-[5-(2-Chloro-1-hydroxyethyl)-2- ethoxyphenyl]-1,6-dihydro-1-methyl-3-propyl-7H-pyrazolo[4,3-d] 1391054-00-4 pyrimidin-7-one) | 1391054-00-4 | C19H23ClN4O3 |
| Hydroxychlorodenafil (5-[5-(2-Chloro-1-hydroxyethyl)-2-ethoxyphenyl]-1,6-dihydro-1-methyl-3-propyl-7H-pyrazolo[4,3-d]pyrimidin-7-one) | 1391054-00-4 | C19H23ClN4O3 |
| Hydroxychloroquine Acid | 645406-24-2 | C18H24ClN3O3 |
| Hydroxychloroquine Diethanol | Not available | C19H28ClN3O2 |
| Hydroxychloroquine dimer | 2732209-42-4 | C36H50Cl2N6O |
| Hydroxychloroquine Dimer | Not available | C36H50Cl2N6O |
| Hydroxychloroquine N-Oxide Dihydrochloride | 2725355-06-4 | C18H28Cl3N3O2 |
| Hydroxychloroquine N-Oxide Dihydrochloride | Not available | C18H28Cl3N3O2 |
| Hydroxychloroquine sulfate EP impurity A | 1449223-88-4 | C18H26ClN3O2 |
| Hydroxychloroquine sulfate EP impurity B | 103152-84-7 | C18H26ClN3O4S |
| Hydroxychloroquine sulfate EP impurity C | 4298-15-1 | C16H22ClN3O |
| Hydroxychloroquine sulfate EP impurity D | 1476-52-4 | C16H22ClN3 |
| Hydroxychloroquine sulfate EP impurity E | 10500-64-8 | C14H17ClN2O |
| Hydroxychloroquine sulfate EP impurity F | 6281-58-9 | C14H15ClN2 |
| Hydroxychloroquine sulfate EP impurity G | 86-98-6 | C9H5Cl2N |
| Hydroxychloroquine sulfate impurity 2 | 47493-14-1 | C20H28ClN3O2 |
| Hydroxydehydro Nifedipine Carboxylate | 34783-31-8 | C16H14N2O7 |
| Hydroxydipegylacetic acid | 51951-04-3 | C6H12O5 |
| Hydroxyethyl Salicylate Imp. A (EP): Salicylic Acid | 69-72-7 | C7H6O3 |
| Hydroxyethyl Salicylate Imp. B (EP): Ethane-1,2-diol (Ethylene Glycol) | 107-21-1 | C2H6O2 |
| Hydroxyhomosildenafil | 139755-85-4 | C23H32N6O5S |
| Hydroxyl- Α- Zanthoxylin | 83883-10-7 | C16H25NO2 |
| Hydroxymetazoline EP impurity B hydrochloride | 1218-35-5 | C16H25ClN2 |
| Hydroxymethyl Clenbuterol-D6 | 1346601-00-0 | C12H18Cl2N2O2 |
| Hydroxymethyl Ivacaftor | 1246213-23-9 | C24H28N2O4 |
| Hydroxymethylcelecoxib (4-[5-[4-(Hydroxymethyl)phenyl]-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide) | 170571-00-3 | C17H14F3N3O3S |
| hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone ((3'R)- Ezetimibe) | 163380-16-3 | C24H21F2NO3 |
| Hydroxypyruvic acid | 997-10-4 | C3H4O3 |
| Hydroxytanshinone IIA | 18887-18-8 | C19H18O4 |
| Hydroxythiovardenafil | 912576-30-8 | C23H32N6O4S2 |
| Hydroxyvardenafil | 224785-98-2 | C23H32N6O5S |
| Hydroxyzine Acetic Acid Dihydrochloride | 83881-56-5 | C23H31Cl3N2O4 |
| Hydroxyzine Hydrochloride Imp. A (EP): (RS)-1-[(4-Chlorophenyl)- phenylmethyl]piperazine | 303-26-4 | C17H19ClN2 |
| Hydroxyzine Hydrochloride Imp. B (EP) as Dihydrochloride: 2-[2-[4- (Diphenylmethyl)piperazin-1-yl]ethoxy]- ethanol Dihydrochloride (Decloxizine Dihydrochloride) | 13073-96-6 | C21H30Cl2N2O2 |
| Hydroxyzine Related Compound A | 303-26-4 | C17H19ClN2 |
| Hymecromone Acetate | 2747-05-9 | C12H10O4 |
| Hymecromone Imp. A (EP): 1,3-Dihydroxybenzene (Resorcinol) | 108-46-3 | C6H6O2 |
| Hymecromone Imp. B (EP): 7-Hydroxy-2-methyl-4H-1- benzopyran-4-one | 6320-42-9 | C10H8O3 |
| Hymecromone impurity A | 108-46-3 | C6H6O2 |
| Hymecromone impurity B | 6320-42-9 | C10H8O3 |
| Hyocholic Acid | 547-75-1 | C24H40O5 |
| Hyoscine butylbromide for system suitability | 149-64-4 | C21H30BrNO4 |
| Hyoscine Butylbromide Imp. A (EP) as Hydrobromide Trihydrate: | 6533-68-2 | C17H28BrNO7 |
| Hyoscine Butylbromide Imp. B (EP): (2RS)-3-Hydroxy-2-phenylpropanoic Acid (DL-Tropic Acid; Tropic Acid) | 552-63-6 | C9H10O3 |
| Hyoscine hydrobromide impurity B | 4684-28-0 | C16H19NO4 |
| Hyoscine impurity A | 4684-28-0 | C16H19NO4 |
| Hyoscine N-Oxide Hydrobromide | 6106-81-6 | C17H22BrNO5 |
| Hyoscine Propylbromide | Not available | C20H28BrNO4 |
| Hyoscyamine impurity E | 537-29-1 | C16H21NO3 |
| Hyoscyamine N-Oxide Hydrochloride | 200721-88-6 | C17H24ClNO4 |
| Hyoscyamine N-Oxide Hydrochloride | 200721-88-6 | C17H24ClNO4 |
| Hyoscyamine Sulfate Imp. A (EP): (2RS)-3-Hydroxy-2- phenylpropanoic Acid (DL-Tropic Acid; Tropic Acid) | 552-63-6 | C9H10O3 |
| Hyoscyamine Sulfate Imp. D (EP) as Hydrobromide Trihydrate: | 6533-68-2 | C17H28BrNO7 |
| Hyoscyamine Sulfate Imp. G (EP) as Hydrochloride: (1R,3r,5S)-8-Methyl- 8-azabicyclo[3.2.1]oct-3-yl 2-Phenylprop-2-enoate Hydrochloride (Apoatropine Hydrochloride) | 5978-81-4 | C17H22ClNO2 |
| Hypoxanthine | 68-94-0 | C5H4N4O |
| Hyssonarin | 3215-70-1 | C22H32N2O6 |
| Ibandronate Impurity 2 | 2377035-78-2 | C8H18ClNO2 |
| Ibandronate Impurity 5 | 26153-88-8 | C7H17N |
| Ibandronate Impurity 8 | 99282-17-4 | C5H11FO7P2 |
| Ibandronate Impurity 10 | 905808-25-5 | C8H21NO7P2 |
| Ibandronate Impurity 13 | 40870-84-6 | C9H19NO2 |
| Ibandronate Related Compound A | 625120-81-2 | C9H20ClNO2 |
| Ibandronate sodium impurity 3 | 953805-81-7 | C8H20NNaO7P2 |
| Ibandronate sodium salt monhydrate | 138926-19-9 | C9H24NNaO8P2 |
| Ibrutinib Dimer | 2031255-23-7 | C50H48N12O4 |
| Ibrutinib Dimer (~90%) | Not available | C50H48N12O4 |
| Ibrutinib Impurity 5 | 1288338-96-4 | C25H25ClN6O2 |
| Ibrutinib Impurity 8 | 330786-24-8 | C17H13N5O |
| Ibrutinib Impurity 18 | 1022150-12-4 | C22H22N6O |
| Ibrutinib impurity 20 | 1839090-60-6 | C25H24N6O4 |